Early Doxorubicin Myocardial Injury: Inflammatory, Oxidative Stress, and Apoptotic Role of Galectin-3
Open Access
- 18 October 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (20) , 12479
Abstract
Doxorubicin (DOXO) is an effective drug that is used in the treatment of a large number of cancers. Regardless of its important chemotherapeutic characteristics, its usage is restricted because of its serious side effects; the most obvious is cardiotoxicity, which can manifest acutely or years after completion of treatment, leading to left ventricular dysfunction, dilated cardiomyopathy, and heart failure. Galectin 3 (Gal-3) is a beta galactoside binding lectin that has different roles in normal and pathophysiological conditions. Gal-3 was found to be upregulated in animal models, correlating with heart failure, atherosclerosis, and myocardial infarction. Male C57B6/J and B6.Cg-Lgals3 <tm 1 Poi>/J Gal-3 knockout (KO) mice were used for a mouse model of acute DOXO-induced cardiotoxicity. Mice were given DOXO or vehicle (normal saline), after which the mice again had free access to food and water. Heart and plasma samples were collected 5 days after DOXO administration and were used for tissue processing, staining, electron microscopy, and enzyme-linked immunosorbent assay (ELISA). There was a significant increase in the heart concentration of Gal-3 in Gal-3 wild type DOXO-treated mice when compared with the sham control. There were significantly higher concentrations of heart cleaved caspase-3, plasma troponin I, plasma lactate dehydrogenase, and plasma creatine kinase in Gal-3 KO DOXO-treated mice than in Gal-3 wild type DOXO-treated mice. Moreover, there were significantly higher heart antioxidant proteins and lower oxidative stress in Gal-3 wild type DOXO-treated mice than in Gal-3 KO DOXO-treated mice. In conclusion, Gal-3 can affect the redox pathways and regulate cell survival and death of the myocardium following acute DOXO injury.Keywords
Funding Information
- College of Medicine & Health Sciences, United Arab Emirates University, CMHS (NP-18-29)
This publication has 56 references indexed in Scilit:
- Lectins Offer New Perspectives in the Development of Macrophage-Targeted Therapies for COPD/EmphysemaPLOS ONE, 2013
- Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesPediatrics, 2012
- Characterization of Blood Oxidative Stress in Type 2 Diabetes Mellitus Patients: Increase in Lipid Peroxidation and SOD ActivityOxidative Medicine and Cellular Longevity, 2012
- Mechanism of anthracycline-mediated down-regulation of GATA4 in the heartCardiovascular Research, 2010
- Galectin-3 in Cardiac Remodeling and Heart FailureCurrent Heart Failure Reports, 2010
- Doxorubicin CardiomyopathyCardiology, 2009
- Cardiomyocyte death in doxorubicin-induced cardiotoxicityArchivum Immunologiae et Therapiae Experimentalis, 2009
- A Role for galectin-3 in renal tissue damage triggered by ischemia and reperfusion injuryTransplant International, 2008
- Regulation of Cellular Adhesion to Extracellular Matrix Proteins by Galectin-3Biochemical and Biophysical Research Communications, 1998
- Embryonic implantation in galectin 1/galectin 3 double mutant miceDevelopmental Dynamics, 1998